G.Barekat Pharm (XTEH:BRKT1) Operating Cash Flow per Share : IRR (TTM As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Operating Cash Flow per Share?

G.Barekat Pharm's operating cash flow per share for the six months ended in Mar. 2017 was IRR-484.15. G.Barekat Pharm does not have enough years/quarters to calculate the operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2017.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for G.Barekat Pharm's Operating Cash Flow per Share or its related term are showing as below:

XTEH:BRKT1's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.5
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

G.Barekat Pharm Operating Cash Flow per Share Historical Data

The historical data trend for G.Barekat Pharm's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Operating Cash Flow per Share Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Operating Cash Flow per Share

-601.35

-484.15

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Operating Cash Flow per Share	-601.35	-484.15

Competitive Comparison of G.Barekat Pharm's Operating Cash Flow per Share

For the Biotechnology subindustry, G.Barekat Pharm's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G.Barekat Pharm's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Price-to-Operating-Cash-Flow falls into.

G.Barekat Pharm Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

G.Barekat Pharm's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2017 is calculated as

Operating Cash Flow per Share (A: Mar. 2017 )	=	Cash Flow from Operations (A: Mar. 2017 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2017 )
	=	-2643149	/	5459.311
	=	-484.15

G.Barekat Pharm's Operating Cash Flow per Share for the quarter that ended in Mar. 2017 is calculated as

Operating Cash Flow per Share (Q: Mar. 2017 )	=	Cash Flow from Operations (Q: Mar. 2017 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2017 )
	=	-2643149	/	5459.311
	=	-484.15

G.Barekat Pharm Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines